Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2011
10/27/2011US20110263830 Process for the modulation of the antagonistic activity of a monoclonal antibody
10/27/2011US20110263824 Modified biotin-binding protein
10/27/2011US20110263822 Composition for the prophylaxis and treatment of hbv infections and hbv-mediated diseases
10/27/2011US20110263821 Prognosis and risk assessment in stroke patients by determining the level of marker peptides
10/27/2011US20110263816 Metallopeptide catalysts
10/27/2011US20110263688 Coferons and methods of making and using them
10/27/2011US20110263687 Rna molecules and uses thereof
10/27/2011US20110263686 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/27/2011US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011US20110263683 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
10/27/2011US20110263682 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53
10/27/2011US20110263681 Organic Compositions to Treat Beta-ENaC-Related Diseases
10/27/2011US20110263680 Reduced size self-delivering rnai compounds
10/27/2011US20110263679 C12orf48 as a target gene for cancer therapy and diagnosis
10/27/2011US20110263678 Inhibitors of tgf-r signaling for treatment of cns disorders
10/27/2011US20110263677 Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110263676 Small interfering rna for gene knockdown of the subcutaneous n-methyl-d-aspartate receptor nr1 subunit, and it's application on pharmaceutics
10/27/2011US20110263585 Screening Assay for Insecticides
10/27/2011US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity
10/27/2011US20110263514 Delivery of agents using interfering nanoparticles
10/27/2011US20110263513 Pharmaceutical Being Used For Treating Cancer and Fibrosis Disease and the Composition and Uses Thereof
10/27/2011US20110263488 Family of pesticidal proteins and methods for their use
10/27/2011US20110263485 Bifunctional Griffithsin Analogs
10/27/2011US20110263484 Single chain fc type iii interferons and methods of using same
10/27/2011US20110263483 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/27/2011US20110263482 Complement inhibitors
10/27/2011US20110263449 In vitro method and kit for prognosis or prediction of response by patients with rheumatoid arthritis to treatment with tnf-alpha factor blocking agents
10/27/2011US20110263437 Analysis of Y-Chromosome STR Markers
10/27/2011US20110263435 Genetic markers for boar taint
10/27/2011US20110263026 Construction of Protein-Responsive shRNA/RNAi Control System Using RNP Motif
10/27/2011US20110263025 Biodegradable polydisulfide amines for gene delivery
10/27/2011US20110263023 Genes for modulating coffee maturation and methods for their use
10/27/2011US20110263012 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex
10/27/2011US20110262999 Compositions and Methods Comprising Protease Variants
10/27/2011US20110262977 Process for production of optically active amine derivative
10/27/2011US20110262974 Novel enzymes for use in enzymatic bleaching of food products
10/27/2011US20110262973 Methods and Compositions for DNA Manipulation
10/27/2011US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/27/2011US20110262953 Phosphate Limited Inducible Promoter and A Bacillus Expression System
10/27/2011US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus
10/27/2011US20110262918 Improved nanoparticulate compositions of poorly soluble compounds
10/27/2011US20110262916 Non-invasive fetal rhd genotyping from maternal whole blood
10/27/2011US20110262910 Marker for colon cancer and method for detecting colon cancer
10/27/2011US20110262908 Isolation of protein factors that associate directly or indirectly with nucleic acids
10/27/2011US20110262899 Fluorescent labeling of transfer rna and study of protein synthesis
10/27/2011US20110262897 Imaging techniques using a tridentate ligand
10/27/2011US20110262619 Polypeptide having phytase activity and increased temperature resistance of the enzyme activity, and nucleotide sequence coding said polypeptide
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011US20110262479 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/27/2011US20110262478 Recombinant Protein Bodies as Immunogen-Specific Adjuvants
10/27/2011US20110262476 Mutant bacterial glycoproteins and uses thereof
10/27/2011US20110262474 Chimeric HIV Antigens
10/27/2011US20110262471 Rab6kifl/kif20a epitope peptide and vaccines containing the same
10/27/2011US20110262469 Malaria vaccine based on fragments and combination of fragments of the cs protein of plasmodium vivax
10/27/2011US20110262463 Syngr4 for target genes of cancer therapy and diagnosis
10/27/2011US20110262461 Biological materials and uses thereof
10/27/2011US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011US20110262452 Anti-hepsin antibodies and methods using same
10/27/2011US20110262451 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110262450 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110262447 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
10/27/2011US20110262445 Anti-il-12/il-23 antibodies
10/27/2011US20110262441 Method for selective control of helper t cell function
10/27/2011US20110262439 Bispecific single chain antibodies with specificity for high molecular weight target antigens
10/27/2011US20110262437 Use of erbb4 as a prognostic and therapeutic marker for melanoma
10/27/2011US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011US20110262425 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
10/27/2011US20110262423 Suppression of cancer
10/27/2011US20110262411 Bacteriophage derived methods to control lactic acid bacterial growth
10/27/2011US20110262399 Porphobilinogen deaminase gene therapy
10/27/2011US20110262397 Compounds, compositions, and methods for control of hepatitis c viral infections
10/27/2011US20110262394 Dna constructs eliciting immune response against flavivirus and effective adjuvants
10/27/2011US20110262391 Ca9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma
10/27/2011US20110262361 effective new drug target for the treatment of tuberculosis
10/27/2011US20110262358 Molecular marker for cancer stem cell
10/27/2011US20110262347 Methods and compositions for enhanced delivery of compounds
10/27/2011US20110260105 Nucleic acid nanotube liquid crystals and use for nmr structure determination of membrane proteins
10/27/2011CA2833912A1 Aav-based treatment of cholesterol-related disorders
10/27/2011CA2795815A1 Novel structurally designed shrnas
10/26/2011EP2380914A1 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminal end of ec-sod
10/26/2011EP2380911A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function
10/26/2011EP2380910A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function
10/26/2011EP2380900A1 Isolation and use of ryanodine receptors
10/26/2011EP2380899A1 Isolation and use of ryanodine receptors
10/26/2011EP2380897A1 RNAi modulation of ApoB and uses thereof
10/26/2011EP2380896A1 A method for preparing oligonucleotide
10/26/2011EP2379084A2 Modulation of factor 11 expression
10/26/2011EP2379083A2 Extended dicer substrate agents and methods for the specific inhibition of gene expression
10/26/2011EP1692158B1 Vegf binding and supported peptides for treating skin diseases
10/26/2011EP1660678B1 Mutant adeno-associated virus virions and methods of use thereof
10/26/2011EP1520030B1 Microorganisms and processes for enhanced production of pantothenate
10/26/2011EP1409748B1 Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof.
10/26/2011EP1040203B1 Nucleic acid ligand diagnostic biochip
10/26/2011EP0956359B1 High fidelity detection of nucleic acid differences by ligase detection reaction
10/26/2011EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011CN1678624B Benzoate- and anthranilate-inducible promoters
10/26/2011CN102227443A Therapeutic ribonucleases
10/26/2011CN102227440A Improved antibody libraries
10/26/2011CN101423865B Human Toll-like receptor 7 gene mononucleotide polymorphism and use thereof
10/26/2011CN101198706B Nucleic and melting analysis with saturation dyes
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 899